BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1719063)

  • 1. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E; Persson LI; Mumford J; Haegele KD; Huebert N
    J Child Neurol; 1991; Suppl 2():S11-6. PubMed ID: 1719063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy.
    Menachem EB; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP
    Epilepsy Res; 1988; 2(2):96-101. PubMed ID: 3143561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.
    Ben-Menachem E; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):79S-85S. PubMed ID: 2474312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and clinical pharmacology of vigabatrin.
    Richens A
    J Child Neurol; 1991; Suppl 2():S7-10. PubMed ID: 1940127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gamma-vinyl-GABA: first experiences in Italy. II].
    de Romanis F; Sopranzi N
    Clin Ter; 1994 Mar; 144(3):193-9. PubMed ID: 8181215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ; Ylinen A; Halonen T; Sivenius J; Pitkanen A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy.
    Gram L; Klosterskov P; Dam M
    Ann Neurol; 1985 Mar; 17(3):262-6. PubMed ID: 3922282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy.
    Reynolds EH
    Epilepsia; 1992; 33 Suppl 5():S30-4; discussion S34-5. PubMed ID: 1425498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin--plasma enantiomer concentrations and clinical effects.
    Sheean G; Schramm T; Anderson DS; Eadie MJ
    Clin Exp Neurol; 1992; 29():107-16. PubMed ID: 1343855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy.
    Cannon DJ; Butler WH; Mumford JP; Lewis PJ
    J Child Neurol; 1991; Suppl 2():S17-24. PubMed ID: 1940119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin in childhood epilepsy.
    Dulac O; Chiron C; Luna D; Cusmai R; Pajot N; Beaumont D; Mondragon S
    J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gamma-vinyl-GABA: the first trials in Italy].
    de Romanis F; Sopranzi N
    Clin Ter; 1993 Feb; 142(2):145-54. PubMed ID: 8472529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
    Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures.
    Ben Menachem E; Persson L; Schechter PJ; Haegele KD; Huebert N; Hardenberg J
    J Neurochem; 1989 Feb; 52(2):632-5. PubMed ID: 2463340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients].
    Pfersmann D; Saletu B; Semlitsch HV; Anderer P; Dieterich HA
    Wien Med Wochenschr; 1993; 143(6):119-28. PubMed ID: 8517061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.